Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
IRON SUCROSE (IRON SUCROSE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
IRON SUCROSE
ANDA
Get alerts
IRON SUCROSE | A212559 | MYLAN LABORATORIES LTD
3 strengths
0 unique patents
1 unique exclusivity
Reference Listed Drug:
VENOFER
(TE code: AB)
Patents
SEC Intel
Revenue
DMF
Label
Products
Patent Timeline
0 unique patents, 1 exclusivity by expiration date
All strengths
EQ 50MG IRON/2.5ML (EQ 20MG IRON/ML)
EQ 100MG IRON/5ML (EQ 20MG IRON/ML)
EQ 200MG IRON/10ML (EQ 20MG IRON/ML)
Today
Exclusivity
Today
CGT
Feb. 7, 2026
Products (3)
Sort:
Name
↑
Applicant
Strength
Approval
#001 — EQ 50MG IRON/2.5ML (EQ 20MG IRON/ML)
AB
0 patents
0 exclusivities
▴
INJECTABLE;INTRAVENOUS | Approved: Aug 8, 2025
No patent or exclusivity listings for this strength.
#002 — EQ 100MG IRON/5ML (EQ 20MG IRON/ML)
AB
0 patents
1 exclusivity
▾
INJECTABLE;INTRAVENOUS | Approved: Aug 8, 2025
#003 — EQ 200MG IRON/10ML (EQ 20MG IRON/ML)
AB
0 patents
1 exclusivity
▾
INJECTABLE;INTRAVENOUS | Approved: Aug 8, 2025